Milind Deshpande

Affiliations

  • at Spero Therapeutics Inc. (SPRO), 2025-06-17
  • Chief Executive Officer at Achillion Pharmaceuticals Inc (ACHN), 2018-02-13
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ACHN $4.06 2,500 $10,150.00 2,500 2016-12-02 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ACHN $15.00 100,000 $1,500,000.00 0 2015-01-21 Filing
ACHN $10.00 124,424 $1,244,240.00 0 2014-08-18 Filing
ACHN $10.00 60,000 $600,000.00 0 2014-08-18 Filing
ACHN $10.00 15,950 $159,500.00 0 2014-08-18 Filing
ACHN $10.00 16,250 $162,500.00 0 2014-08-18 Filing